The director of the Division of Endocrinology, Diabetes and Metabolism at The University of Texas Health Science Center at Houston (UTHealth) Medical School, Dr. Philip Orlander, has received a distinction from the American Diabetes Association (ADA) “for his lifetime of treatment and research into both Type 1 and Type 2 diabetes,” said Houston ADA Executive Director Ralston Creswell.
Orlander was chosen by some of his peers and business leaders from the ADA’s leadership board, and he was presented with the award during a fundraising gala, the 2014 Wine’s and Roses Auction and Gala at the Royal Sonesta Hotel, which collected over $500,000 for the fight against diabetes.
According to UTHealth, this new award is one of many highlighting Dr. Orlander’s work, which has been frequently recognized throughout his career.
Dr. Orlander is a Distinguished Teaching Professor of The University of Texas System. He is the recipient of the university’s Herbert L. and Margaret W. DuPont Master Clinical Teaching Award, the Award for Humanism in Medicine and multiple Dean’s Excellence in Teaching Awards.
Orlander is on the medical staff of Memorial Hermann-Texas Medical Center and Harris Health Lyndon B. Johnson Hospital.
He joined the faculty of the UTHealth Medical School in 1983 and was named division director in 1993. He is an assistant dean of educational programs at the UTHealth Medical School.
His student background is divided between the U.S., where he received his undergraduate degree from New York University, and Belgium, where he received his medical degree from the Free University in Brussels.
The ADA also recognized two other UTHealth Physicians of the Year, Victor Lavis, M.D., professor of internal medicine, and Charles A. Garcia, M.D., professor of ophthalmology and visual sciences and holder of the Bernice Weingarten Chair in Ophthalmology.
400,000 children and adults in Houston have diabetes, a disease that can lead to complications like blindness or amputation. It is believed that by 2050, one out three people in the U.S. will be diagnosed with diabetes.